(+/-)-TRICARBONYL-[(2,3,4,5-ETA)-SPIRO-[4-METHOXY-2,4-CYCLOHEXADIENE-1,1'(3'H)-5',6'-DIMETHOXY-3'-(PHENYLETHYNYL)-ISOBENZOFURAN]]-IRON-(0)
Compound with spectra: 1 NMR
![(+/-)-TRICARBONYL-[(2,3,4,5-ETA)-SPIRO-[4-METHOXY-2,4-CYCLOHEXADIENE-1,1'(3'H)-5',6'-DIMETHOXY-3'-(PHENYLETHYNYL)-ISOBENZOFURAN]]-IRON-(0)](/api/compound/GPkPWmItDTj.png?ph=true&h=300&w=458 "(+/-)-TRICARBONYL-[(2,3,4,5-ETA)-SPIRO-[4-METHOXY-2,4-CYCLOHEXADIENE-1,1'(3'H)-5',6'-DIMETHOXY-3'-(PHENYLETHYNYL)-ISOBENZOFURAN]]-IRON-(0)")
| SpectraBase Compound ID | GPkPWmItDTj |
|---|---|
| InChI | InChI=1S/C24H19O4.3CO.Fe/c1-25-18-11-13-24(14-12-18)20-16-23(27-3)22(26-2)15-19(20)21(28-24)10-9-17-7-5-4-6-8-17;3*1-2;/h4-8,15-16,21H,13H2,1-3H3;;;;/t21-,24-;;;;/m0..../s1 |
| InChIKey | WLLMPFBKTCNOLO-AFWSTIGFSA-N |
| Mol Weight | 511.29 g/mol |
| Molecular Formula | C27H19FeO7 |
| Exact Mass | 511.048014 g/mol |
| Enantiomer InChIKey | WLLMPFBKTCNOLO-CQMLMSOMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Methyl 2.beta.-(2'-(m-isopropyl-phenyl)ethyl)-1.beta.,3.alpha.-dimethyl-cyclohexanecarboxylate (so name and structure in Anderson & Botto) but MS (intense fragement at m/z = 187) and RT suggest 2.alpha.-epimer instead, with Reg. No. 19556-80-0? a methyl seco-dehydro-abietate
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
6H,10H,16H,18H,32H,34H-5,9:17,21-Dimethano-11,15-metheno-1,25[1',3']-pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazacyclohexa cosine-32,37,39-trione, 7,8,19,20,28,29,35,36-octahydro-38-methoxy-13-methyl-
{(4a,5,6,7,7a-.eta.)-4-(2",2"-Dimethyl-1",3"-dioxolan-4"-yl)-3a,5,8,8a-tetrahydro-2,2-dimethyl-4H-indeno[5,6-d]-1,3-dioxol-5-yl}-{(4',5',6',7',7a'-.eta.)-5'-(chloromercurio)-4'-(2"',2"'-dimethyl-1'",3'"-dioxolan-4"'-yl}-3a',5',8',8a'-tetrahydro-2',2'-dimethyl-4H-indeno5,6-d]-1',3'-dioxol-5'-yl}- iron (II)
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
N-[4-[(2-chlorophenyl)[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl]methylene]-2,5-cyclohadien-1-ylidene]-N-ethyl-3-sulfobenzenemethanaminium trihydrogen {(trioxotungstato)(trioxomolybdato)phosphate]
Cobalt, bis(cyano-C)(8,11-diethyl-2,3,3a,7,8,9,10,11,12,16,17,20a-dodecahydro-3a,5,8,9,12,14,17,17-octamethyl-7,12,16,20a-tetrapropyl-10,13-imino-4,20:9,16:18,15-trinitrilo-6H-cyclononadeca[b]furanato-N21,N22,N23,N24)-, stereoisomer
(2S,5S*,7S*,9S,1-S,12R,13Z,15R)-2-[(2R,5R,6S)-5-Benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-9-[(R)-1-ethyl-2-oxobutyl]-15-(4-methoxybenzyloxy)-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.3.5]pentadec-13-ene
38-(3,5-Dimethylphenyl)-7,8,19,20,28,29,35,36-octahydro-6H,10H,16H,32H,34H-59:17,21-dimethano-11,15-metheno-1,2,5-[1',3']pyrimidino-5H,27H-dibenzo[b,u][1,23,4,8,16,20]dioxatetraazacyclohexacosine-32,37,39-trione
| Title | Journal or Book | Year |
|---|---|---|
| Influencing the Balance between ipso and ω Nucleophile Addition to (1-Arylcyclohexadienyl)iron Intermediates in Alkaloid Synthesis | European Journal of Organic Chemistry | 2012 |